Manuel Rosa‐Calatrava

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

Andrés Pizzorno, Blandine Padey, Thomas Julien et al. · Cell Reports Medicine · 2020 · 238 citations · Full text

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load

António Gonçalves, Julie Bertrand, Ruian Ke et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 232 citations · Full text

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2

Andrés Pizzorno, Blandine Padey, Julia Dubois et al. · Antiviral Research · 2020 · 165 citations · Full text

Antiviral Agents, Antiviral Activity, Medicine +11

A quasi‐atomic model of human adenovirus type 5 capsid

C.M.S. Fabry, Manuel Rosa‐Calatrava, James F. Conway et al. · The EMBO Journal · 2005 · 140 citations · Full text

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs

Jonathan Lopez, Marine Mommert, William Mouton et al. · The Journal of Experimental Medicine · 2021 · 127 citations · Full text

Nasal Mucosa, Lung Inflammation, Viral Immunity +20